The global demand for High Flow Nasal Cannula Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
High-flow nasal cannula (HFNC) therapy refers to an oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 60 litres per minute. All settings and components are controlled independently allowing for greater efficiency in the delivery of supplemental oxygen as well as better outcomes when used. It offers several benefits: very high flow rates of gas in an attempt to match a patient's inspiratory flow demands and provides the benefit of PEEP and increased oxygen saturation that NIV supplies. It is clinically utilized in a wide spectrum of patient care arenas in critical care units, emergency departments, and end-of-life scenarios.
Respiratory distress is one of the most common causes of hospitalization. Respiratory support using heated humidified high-flow nasal cannula (HFNC) therapy has become an established practice in neonatal intensive care. It has been increasingly used in a variety of clinical settings. HFNC therapy has a potential clinical advantage in the management of children hospitalized with respiratory distress compared with conventional oxygen therapy. It overcomes flow limitations of low- and intermediate-flow devices by delivering up to 60 litres per minute of heated, humidified gas through nasal prongs. The growing aging population, burden of respiratory diseases, and expansion of public expansion are factors driving the growth of the market. Developing countries are improving access to healthcare and is executing pan of expansion at the fastest pace.
Currently, the market is experiencing an exceptional phase owing to the coronavirus outbreak leading even to a shortage in supply. The primary approach for COVID-19 patients is supportive care which includes oxygen therapy for hypoxemic patients, in which high-flow nasal cannula (HFNC) was reported as effective in improving oxygenation. COVID-19 is an emerging and rapidly evolving situation. As a result, the demand for HFNC is contributing to the critical shortage worldwide. This brings and uncertainity and restrain to growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of High Flow Nasal Cannula.
The entire High Flow Nasal Cannula market has been sub-categorized into application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By End User
- Acute Respiratory Failure
- Acute Heart Failure
- Chronic Obstructive Pulmonary Disease
- Long-Term Care Centers
This section covers regional segmentation which accentuates on current and future demand for High Flow Nasal Cannula market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global High Flow Nasal Cannula Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the High Flow Nasal Cannula market include Great Group Medical Co., Ltd., Salter Labs, TNI Medical Ag, Mek-Ics Co., Ltd., Flexicare Medical Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.